跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 49,888 条关于
“HDT Bio Canada Inc.”
全部
49,888
临床试验
16,875
药物
2,948
机构
6,439
资讯
23,626
2个月前
HDT Bio Launches Canadian Phase 1 Trial of HDT-401, a Locally Administered RNA Immune Activator for Glioblastoma
12个月前
FDA Clears HDT Bio's First-in-Class HDT-321 for Crimean-Congo Hemorrhagic Fever Prevention
去年
INmune Bio's XPro Shows Promise in Alzheimer's, Faces Financial Hurdles
去年
OmniScience and INmune Bio Partner to Accelerate Alzheimer's Clinical Trial with AI
去年
Annovis Bio's Buntanetap Shows Promise in Neurodegenerative Disease Treatment
2年前
INmune Bio Announces $12 Million Offering to Advance Clinical Programs
去年
INmune Bio Completes Enrollment in Phase 2 Alzheimer's Trial Targeting Neuroinflammation
去年
Phase 2 Trial Evaluates Host-Directed Therapies for Rifampicin-Resistant Tuberculosis
去年
INmune Bio's XPro™ Promotes Remyelination in Animal Models, Showing Promise for Alzheimer's Treatment
去年
INmune Bio Completes Enrollment in Phase 2 Alzheimer's Trial and Reports Positive NK-Cell Data in Prostate Cancer Study
第 1 页,共 2363 页
上一页
下一页